LVS vs TECH · P/E 28, rev $2.90B vs P/E 65, rev $1.22B
Las Vegas Sands Corp (LVS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported LVS revenue for 2024-12-31 was $2.90B. Net income was $392.0M. Revenue was up 8.0% from 2024-09-30 to 2024-12-31. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
LVS currently screens at market cap $35.70B and trailing P/E 28.3. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the LVS and TECH stock pages for the full models.
Not investment advice.